- Home
- SXTP vs NBY Comparison
SXTP vs NBY Comparison
Compare SXTP & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- NBY
- Stock Information
- Founded
- SXTP 2010
- NBY 2000
- Country
- SXTP United States
- NBY United States
- Employees
- SXTP N/A
- NBY N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- NBY
- Sector
- SXTP Health Care
- NBY
- Exchange
- SXTP Nasdaq
- NBY Nasdaq
- Market Cap
- SXTP 2.7M
- NBY 2.8M
- IPO Year
- SXTP 2023
- NBY 2007
- Fundamental
- Price
- SXTP $0.83
- NBY $0.73
- Analyst Decision
- SXTP Hold
- NBY Strong Buy
- Analyst Count
- SXTP 1
- NBY 1
- Target Price
- SXTP N/A
- NBY $0.85
- AVG Volume (30 Days)
- SXTP 967.9K
- NBY 492.7K
- Earning Date
- SXTP 11-14-2024
- NBY 11-07-2024
- Dividend Yield
- SXTP N/A
- NBY N/A
- EPS Growth
- SXTP N/A
- NBY N/A
- EPS
- SXTP N/A
- NBY N/A
- Revenue
- SXTP $462,612.00
- NBY $13,844,000.00
- Revenue This Year
- SXTP $141.35
- NBY N/A
- Revenue Next Year
- SXTP $175.16
- NBY $17.31
- P/E Ratio
- SXTP N/A
- NBY N/A
- Revenue Growth
- SXTP 128.99
- NBY 15.40
- 52 Week Low
- SXTP $0.70
- NBY $0.07
- 52 Week High
- SXTP $10.67
- NBY $6.30
- Technical
- Relative Strength Index (RSI)
- SXTP 36.41
- NBY 63.10
- Support Level
- SXTP $0.87
- NBY $0.65
- Resistance Level
- SXTP $0.95
- NBY $0.78
- Average True Range (ATR)
- SXTP 0.14
- NBY 0.06
- MACD
- SXTP -0.06
- NBY 0.01
- Stochastic Oscillator
- SXTP 6.99
- NBY 83.07
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.